echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Hengkang Pharmaceuticals is notified of fines for producing and selling inferior drugs

    Hengkang Pharmaceuticals is notified of fines for producing and selling inferior drugs

    • Last Update: 2021-03-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    , Jiangxi Provincial Drug Administration issued the "Jiangxi Hengkang Pharmaceutical Co., Ltd. production and sale of inferior drugs administrative penalty information disclosure table" shows that Jiangxi Hengkang Pharmaceutical Co., Ltd. ("Hengkang Pharmaceuticals") for the production and sale of inferior drugs were confiscated illegal income of 1478 million yuan, and fined 1478 million yuan, a total of 295,600 fines.It is worth mentioning that Hengkang Pharmaceuticals has been notified and punished by several provincial and municipal regulatory authorities on several occasions during 2018 due to drug quality issues.On February 13, 2018, the Hubei Provincial Drug Administration issued the "Pharmaceutical Quality Bulletin of Hubei Province (No. 4 of 2017)" showing that three batches of cough turin capsules produced by Hengkang Pharmaceuticals (lot numbers 20170680, 20170212, 20170218) were found to be non-compliant.On May 14, 2018, the Anhui Provincial Drug Administration issued the "Anhui Province Drug Quality Bulletin (No. 3 of 2018, No. 49)" showing that Hengkang Pharmaceuticals produced cough Turing capsules (lot number 20170311) "symptoms", "inspection" items were found to be non-compliant by the Maanshan City Food and Drug Inspection Center.On July 5, 2018, the Hubei Provincial Drug Administration issued the "Pharmaceutical Quality Bulletin of Hubei Province (No. 2 of 2018)" showing that two batches of cough Turing capsules (lot number 20170106, 20170309) produced by Jiangxi Hengkang Pharmaceutical Co., Ltd. were detected by the Xiantao City Food and Drug Inspection and Inspection Center as "status" and "moisture" items do not meet the requirements.On October 29, 2018, the Hebei Provincial Drug Administration issued the "Hebei Province Drug Quality Bulletin (No. 3 of the 2018 Drug Supervision and Inspection Phase 3)" showing that Hengkang Pharmaceuticals' Nofluorosa Star Capsules (Lot No. 20170503) were found to be "dissolved degree" did not meet the requirements.On December 4, 2018, the Guangdong Provincial Drug Administration issued the "Notice on Drug Spot Check Testing Information No. 11 of 2018" shows that Hengkang Pharmaceuticals' cough turing capsules (lot number 20170329) were detected by the Qingyuan City Food and Drug Inspection Institute "symptoms", "moisture" items do not meet the requirements.
    (Sina Pharmaceutical News)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.